After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Each company has approaching catalysts.
The Consumer Union is alleging that Mylan may have paid Teva to withhold its EpiPen competitor from the market.
When it comes to investing in health care, hedge fund pro John Paulson knows his stuff.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.